Indian pharma manufacturers are pushing for input price caps as raw material costs surge sharply. Smaller companies warn that without support, rising expenses and tight drug price controls could disrupt medicine supply.
Akums Drugs & Pharmaceuticals has launched Lasmiditan dispersible tablet aimed at providing faster and easier relief during acute migraine attacks.
Merck reveals new clinical data on heart and lung diseases at ACC.26, showcasing promising treatments for high cholesterol and heart failure, offering hope for millions.
.png "Zydus & Torrent Partner to Co-Market Semaglutide Injection")
Zydus Lifesciences Limited and Torrent Pharmaceuticals Limited today announced a licensing and supply agreement to co market semaglutide injection in India.
Indian pharma major Strides Pharma Science has announced a significant Strides Pharma Africa expansion by acquiring a portfolio of branded generic medicines from Sandoz AG.
Pfizer Inc. today reported positive topline findings from its Phase 2 FOURLIGHT-1 trial, marking a key milestone in the atirmociclib breast cancer study for patients with HR-positive HER2-negative metastatic breast cancer...
Ajanta Pharma, Sun Pharma, and Lupin are in focus as Ozempic Patent Expiry drives surge in pharma stocks ahead of launch, with companies gearing up for semaglutide generics in the fast-growing diabetes and weight-loss market.
Bharat Biotech is advancing vaccines to fight drug resistance, focusing on preventing hospital infections and reducing antibiotic use as antimicrobial resistance grows into a major global health threat.
Union Minister Jitendra Singh lays foundation for Rs 600 crore pharmaceutical facility in Kathua to boost India’s self-reliance in critical antibiotic manufacturing and reduce import dependence.
AstraZeneca Pharma India has received regulatory approval for Durvalumab for liver cancer treatment in India, marking a significant step in expanding cancer care options.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")